Other
Arterial Stiffness
0
Pipeline Programs↗
3
Active Trials↗
1
Companies Involved↗
Arterial Stiffness is an early-stage landscape with 0 programs across 1 company. The most active players are GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
18
clinical trials
Completed13 · 72%
Recruiting3 · 17%
Unknown status1 · 6%
Terminated1 · 6%
Clinical Trials
Trial Activity
18 trials
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
Recruiting·—·Phase 2·NCT03821623·118 enrolled
The Effect of Vitamin D Supplementation on Arterial Stiffness in Diabetic Patients
Completed·—·N/A·NCT01500005·74 enrolled
Atorvastatin Effects On Arterial Stiffness In Hemodialysis
Completed·—·Phase 2·NCT04472637·50 enrolled
The Effect of Anacetrapib on Vascular Function and Arterial Stiffness
Completed·—·N/A·NCT02931188·103 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)